Evidence map›Paper›PMID 40530813›Full record

ArticleMicrobiology spectrum2025

A benchmark dataset for validating

Elizabeth Misas, Lindsay A Parnell, Malavika Rajeev, Luisa F López, Amanda Ribeiro Dos Santos, Zachary B Mudge, Lalitha Gade, Kaitlin Forsberg, Meghan Lyman, D Joseph Sexton and 3 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Micafungin exposure drives multidrug resistance inbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Journal of fungi (Basel, Switzerland) · 2026
    Review
  5. UnderstandingJournal of medical microbiology · 2026
    Review
  6. ER stress selects forFrontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Elizabeth Misas *Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-6243-7716
Lindsay A Parnell *Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0001-5598-6485
Malavika RajeevMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Luisa F LópezMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Amanda Ribeiro Dos SantosMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-5577-4498
Zachary B MudgeMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Lalitha GadeMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Kaitlin ForsbergMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Meghan LymanMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
D Joseph SextonMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-3099-7334
Anastasia P LitvintsevaMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-1086-8041
Shawn R LockhartMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0002-4383-5994
Nancy A ChowMycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Echinocandins are the recommended antifungal therapy for IMPORTANCE: Echinocandins are the recommended first-line treatment for invasive infections caused by

Indexed as

CandidaCandida aurisDrug Resistance, FungalFungal ProteinsGlucosyltransferasesMutationAntifungal AgentsBenchmarkingCandidiasisComputational BiologyEchinocandinsGenome, FungalHumansMicrobial Sensitivity TestsPhylogenyWhole Genome SequencingAntifungal AgentsEchinocandinsFungal ProteinsGlucosyltransferasesantifungal susceptibility testingCandida aurisechinocandinsFKS1whole genome sequencing

Identifiers

PMID40530813
PMCPMC12323592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.